Literature DB >> 10357798

Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1.

W R Fields1, C S Morrow, J Doehmer, A J Townsend.   

Abstract

Aflatoxin B1 (AFB1) is activated to AFB1-8,9-oxide (AFBO), a potent mutagenic and carcinogenic metabolite of AFB1. In the mouse, AFBO has been shown to be most efficiently detoxified by a specific isozyme of alpha-class glutathione S-transferase (GST), mGSTA3-3 (mGST-Yc). A hamster V79 cell line (V79MZr2B1, originally designated V79/SD1) previously transfected with the rat cytochrome P450-2B1 was stably transfected with an mGSTA3-3 expression vector, to study the chemopreventive role of GST in protecting against cytotoxicity or genotoxicity of AFBO. Immunoblotting demonstrated strong expression of an alpha-class GST in the mGSTA3-3 transfected cell line, whereas no detectable alpha-class GST protein was observed in the control (empty vector-transfected) cells. Previous studies with the V79MZr2B1 cell line indicated that it can activate AFB1 to a mutagenic metabolite via a transfected rat P450-2B1 stably expressed in the cells. We examined the ability of the expressed mGSTA3-3 to protect against AFB1-induced cytotoxicity or [3H]-covalent adduct formation in cellular nucleic acids. Exposure of empty vector-transfected control cells and mGSTA3-3 expressing cells to up to 600 nM [3H]-AFB1 indicated that a 70-80% reduction in DNA and RNA adducts was afforded by the expression of mGSTA3-3 in the transfected cells. Clonogenic survival assays showed that the mGSTA3-3 cell line was 4.6-fold resistant to AFB1 cytotoxicity as compared with the empty vector-transfected control SD1 cells, with IC50 values of 69 and 15 microM, respectively. The results of these studies demonstrate that mGSTA3-3 confers substantial protection against nucleic acid covalent modification and cytotoxicity by AFB1 in this transgenic cell model system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357798     DOI: 10.1093/carcin/20.6.1121

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

2.  Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China.

Authors:  Thomas W Kensler; Derek Ng; Steven G Carmella; Menglan Chen; Lisa P Jacobson; Alvaro Muñoz; Patricia A Egner; Jian Guo Chen; Geng Sun Qian; Tao Yang Chen; Jed W Fahey; Paul Talalay; John D Groopman; Jian-Min Yuan; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2011-11-01       Impact factor: 4.944

Review 3.  NRF2, cancer and calorie restriction.

Authors:  A Martín-Montalvo; J M Villalba; P Navas; R de Cabo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

4.  miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.

Authors:  Gabriel Eades; Muhua Yang; Yuan Yao; Yongshu Zhang; Qun Zhou
Journal:  J Biol Chem       Date:  2011-09-16       Impact factor: 5.157

5.  Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice.

Authors:  Kevin H Kensler; Stephen L Slocum; Dionysios V Chartoumpekis; Patrick M Dolan; Natalie M Johnson; Zoran Ilic; Dana R Crawford; Stewart Sell; John D Groopman; Thomas W Kensler; Patricia A Egner
Journal:  Toxicol Sci       Date:  2014-03-27       Impact factor: 4.849

6.  Cytotoxicity and mutagenicity of 5-methylchrysene and its 1,2-dihydrodiol in V79MZ cells modified to express human CYP1A1 or CYP1B1, in the presence or absence of human GSTP1 coexpression.

Authors:  Sarfaraz Ahmad; Sandra L Kabler; Lisa Rudd; Shantu Amin; Johannes Doehmer; Charles S Morrow; Alan J Townsend
Journal:  Toxicol Lett       Date:  2008-10-22       Impact factor: 4.372

7.  Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1.

Authors:  Zoran Ilic; Dana Crawford; Dilip Vakharia; Patricia A Egner; Stewart Sell
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-20       Impact factor: 4.219

Review 8.  Nrf2: friend or foe for chemoprevention?

Authors:  Thomas W Kensler; Nobunao Wakabayashi
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

9.  Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Authors:  Bill D Roebuck; Denise N Johnson; Carrie Hayes Sutter; Patricia A Egner; Peter F Scholl; Marlin D Friesen; Karen J Baumgartner; Nicholas M Ware; Sridevi Bodreddigari; John D Groopman; Thomas W Kensler; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2009-01-23       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.